Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
New studies suggest that that GLP-1 medications may be linked to a 30% higher risk of developing osteoporosis, especially in people with Type 2 diabetes
517,518 lncRNA NORAD is downregulated in the aorta of patients with aortic dissection, and overexpression of NORAD promotes the growth of vascular smooth muscle cells (VSMCs) and inhibits ferroptosis induced by AngII
Omar, B
Filing type confirmed: BLA, not NDA Eli Lilly will submit a Biologics License Application (retatrutide is regulated as a biologic), expected Q1 2027 (shifted from the previously estimated Q4 2026)
[PMID: 1675926] PubMed record related to this compound for laboratory literature review
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
US$ 29.72
US$ 27.33
US$ 22.66
US$ 22.61
US$ 28.58
